ArticleCurrent oncology (Toronto, Ont.)2023

How We Manage Patients with Indolent B-Cell Malignancies on Bruton's Tyrosine Kinase Inhibitors: Practical Considerations for Nurses and Pharmacists.

Shannon Nixon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.